GSK reorganizes U.K. manufacturing | July 24, 2017 Issue - Vol. 95 Issue 30 | Chemical & Engineering News
Volume 95 Issue 30 | p. 13 | Concentrates
Issue Date: July 24, 2017

GSK reorganizes U.K. manufacturing

Department: Business
Keywords: Pharmaceuticals, GSK, manufacture, U.K., antibiotics, respiratory, HIV

GlaxoSmithKline says it will spend more than $160 million to boost the manufacture of respiratory and HIV medicines at its sites in Ware and Barnard Castle, Eng­land, and Montrose, Scotland. Separately, the firm says it may sell off its cephalosporin antibiotics business, including manufacturing assets in Barnard Castle and Ulverston, England, and Verona, Italy. GSK will continue to make other antibiotics such as Augmentin and conduct research on new antibiotics. In another move, the firm plans to sell off its Horlicks drink brand in the U.K. and close its Horlicks production site in Slough, England. GSK is also exploring the sale of other food brands.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment